Shanghai's state-owned assets reform concept stocks rose to the daily limit, and Shanghai Material Trade, First Medicine, Shibei High-tech, Kaikai Industry and Shanghai 900 set an international daily limit.The number of second-hand houses in Shenzhen was the highest in a single week in more than three years. It was learned from Shenzhen Real Estate Agency Association that in the 49th week of 2024 (December 2 -8), 2,390 sets of second-hand houses (including self-service) were recorded in the city, an increase of 12.6% from the previous month. The volume of second-hand houses recorded in a single week hit a new high in the past 200 weeks. (Shenzhen Special Zone Daily)The first day of listing, the new shares of Gem Boyuan opened sharply higher, and now it has risen by over 220%.
Argentine President Millay: It is planned to cancel capital controls next year. Argentine President Millay said in a televised speech on December 10 local time that Argentina plans to cancel capital controls next year. Millay said that Argentina's economic team is preparing for structural tax reform, which will abolish 90% of the tax revenue, and the Argentine government will continue to ban institutions, secretariats, deputy secretariats, public companies and every state institution that should not exist in the new year. Demián Reidel, economic adviser to Milai, will announce Argentina's nuclear energy plan in the next few days.The change in the concept of computing power leasing has increased the daily limit of Yakang shares and Chengdi Xiangjiang, and the concept of computing power leasing has increased. Both Yakang shares and Chengdi Xiangjiang have daily limit, and Runze Technology, Yunsai Zhilian, Tongniu Information and Kehua Data have followed suit.The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.
Hong Kong stock Fosun's tourism culture opened 83.25% higher. In the news, the company plans to privatize at a premium of about 95.00%.The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14